Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christine Essner"'
Autor:
Delphine Loirat, Marie Duboys de Labarre, Christine Essner, Ioana Hrab, Jean-Christophe Thery, Christelle Jouannaud, Cristian Villanueva, Perrine Vuagnat, Pauline Soibinet-Oudot, Anne Creisson, Audrey Mailliez, Jean-Loup Mouysset, Laura Salabert, Nadine Dohollou, Jean-David Fumet, Thibault De La Motte Rouge, Jean-Michel Vauthier, Maylis Decrop, Pascal Pujol
Publikováno v:
Cancer Research. 82:P1-18
Background: Talazoparib (TALA) is a highly potent PARP inhibitor that has demonstrated clinical benefit in the phase III EMBRACA trial for patients with germline BRCA1 or BRCA2-mutation and a locally advanced or metastatic HER2 negative (HER2-) breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3331ea6e6238567052eb02691100224
https://doi.org/10.1158/1538-7445.sabcs21-p1-18-28
https://doi.org/10.1158/1538-7445.sabcs21-p1-18-28
Autor:
Olivier Bouché, Claire Carlier, Christine Essner, Adeline Debreuve-Theresette, Mathias Brugel, Yacine Merrouche, Marie Françoise Beck
Publikováno v:
The Oncologist
Oncologist
Oncologist
The coronavirus disease 2019 (COVID-19) pandemic may have affected cancer management. We aimed to evaluate changes in every oncology care pathway essential step, from screening to treatment, during the pandemic. Monthly oncological activity differenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d01aa1e1c9fdb47fd8f42b9f1d6387